ATE169680T1 - 6-o-methylguanin-dna-methyltransferase (mgmt) spezifische antikörper - Google Patents

6-o-methylguanin-dna-methyltransferase (mgmt) spezifische antikörper

Info

Publication number
ATE169680T1
ATE169680T1 AT94900935T AT94900935T ATE169680T1 AT E169680 T1 ATE169680 T1 AT E169680T1 AT 94900935 T AT94900935 T AT 94900935T AT 94900935 T AT94900935 T AT 94900935T AT E169680 T1 ATE169680 T1 AT E169680T1
Authority
AT
Austria
Prior art keywords
pct
mgmt
hybridoma ecacc
nov
date jun
Prior art date
Application number
AT94900935T
Other languages
English (en)
Inventor
Benjamin Fuk Loi Li
Teck Choon Ayi
Original Assignee
Inst Of Molecul & Cell Biology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Of Molecul & Cell Biology filed Critical Inst Of Molecul & Cell Biology
Application granted granted Critical
Publication of ATE169680T1 publication Critical patent/ATE169680T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/23—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a GST-tag

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT94900935T 1992-11-27 1993-11-29 6-o-methylguanin-dna-methyltransferase (mgmt) spezifische antikörper ATE169680T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929224888A GB9224888D0 (en) 1992-11-27 1992-11-27 Monoclonal antibody

Publications (1)

Publication Number Publication Date
ATE169680T1 true ATE169680T1 (de) 1998-08-15

Family

ID=10725777

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94900935T ATE169680T1 (de) 1992-11-27 1993-11-29 6-o-methylguanin-dna-methyltransferase (mgmt) spezifische antikörper

Country Status (10)

Country Link
US (1) US5817514A (de)
EP (1) EP0670908B1 (de)
AT (1) ATE169680T1 (de)
AU (1) AU688289B2 (de)
CA (1) CA2149867A1 (de)
DE (1) DE69320364T2 (de)
ES (1) ES2119992T3 (de)
GB (1) GB9224888D0 (de)
SG (1) SG48841A1 (de)
WO (1) WO1994012660A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5407804A (en) * 1992-05-22 1995-04-18 Applied Genetics Inc. Assays for O6 -methylguanine-DNA methyltransferase
US6773897B2 (en) * 2000-09-29 2004-08-10 The Johns Hopkins University School Of Medicine Method of predicting the clinical response to chemotherapeutic treatment with alkylating agents
DE60212642T2 (de) * 2001-04-10 2007-06-14 ECOLE POLYTECHNIQUE FéDéRALE DE LAUSANNE Verfahren zur verwendung von o6-alkylguanin-dna-alkyltransferasen
BRPI0706540A2 (pt) 2006-01-18 2011-03-29 Merck Patent Gmbh terapia especìfica usando ligantes de integrina para tratar cáncer
EP2441464B1 (de) 2007-01-18 2014-04-09 Merck Patent GmbH Integrin-liganden zur verwendung in der behandlung von darmkrebs
CA2686848A1 (en) 2007-05-08 2008-11-20 Schering Corporation Methods of treatment using intravenous formulations comprising temozolomide
TR201820051T4 (tr) * 2008-06-19 2019-01-21 Prothix Bv Anti-faktör XI Antikorlarının Trombüs Oluşumunun Engellenmesi Veya Tedavisi İçin Kullanılması
CN102448497A (zh) 2009-05-25 2012-05-09 默克专利有限公司 在癌症治疗中的西仑吉肽的持续给药
CN103153328A (zh) 2010-07-16 2013-06-12 默克专利股份有限公司 肽在乳腺癌和/或骨转移灶的治疗中的用途
CN103974978B (zh) * 2011-11-25 2017-03-08 弗劳恩霍夫应用研究促进协会 用于检测snap/clip标记物的单克隆抗体
BR112014013745B1 (pt) 2011-12-09 2022-06-14 Institut Pasteur Método de teste in vitro, kit de detecção e seu uso, método in vitro de diagnóstico, método de fabricação de kit, e teste de imunosseleção multiplex

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5407804A (en) * 1992-05-22 1995-04-18 Applied Genetics Inc. Assays for O6 -methylguanine-DNA methyltransferase

Also Published As

Publication number Publication date
GB9224888D0 (en) 1993-01-13
AU688289B2 (en) 1998-03-12
CA2149867A1 (en) 1994-06-09
WO1994012660A1 (en) 1994-06-09
DE69320364D1 (de) 1998-09-17
EP0670908A1 (de) 1995-09-13
AU5570594A (en) 1994-06-22
EP0670908B1 (de) 1998-08-12
US5817514A (en) 1998-10-06
DE69320364T2 (de) 1998-12-10
SG48841A1 (en) 1998-05-18
ES2119992T3 (es) 1998-10-16

Similar Documents

Publication Publication Date Title
Harada et al. Identification of early plasma cells in peripheral blood and their clinical significance
TR200002405T2 (tr) İnsan CD40' a karşı antikorlar
FR12C0004I2 (fr) Anticorps contre l'antigene ctla-4 humain et utilisation
AU2001258567A1 (en) Humanised antibodies to the epidermal growth factor receptor
IL138497A0 (en) Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
NZ508381A (en) Antibodies, antagonists and agonists of the death domain containing receptor 5 (DR5)
AU2555297A (en) Monoclonal antibodies specific for the extracellular domain of prostate specific membrane antigen
DE69709632D1 (de) Humanisierte monoklonale anti-cd40 antikörper und fragmente zur hemmung der b-zellaktivierung
ATE169680T1 (de) 6-o-methylguanin-dna-methyltransferase (mgmt) spezifische antikörper
DE69429095D1 (de) Humanisierte antikoerper
SE9103183L (sv) Virus-antikroppskomplex
AR248044A1 (es) Una secuencia de adn que codifica anticuerpos monoclonales humanizados contra interleuquinas humanas, metodo de obtencion y de seleccion de dichos anticuerpos, vector recombinante y celula huesped.
ES2541540T3 (es) Métodos para generar preparados exentos de helper de alto título de vectores de AAV recombinantes liberados
Thomas et al. Decreased expression of CD80 is a marker for increased tumorigenicity in a new murine model of oral squamous‐cell carcinoma
AU4326693A (en) Monoclonal antibodies to glycoprotein p
GR3029483T3 (en) Antibodies against t-cells as therapeutics
ATE206621T1 (de) Il-8 antagonisten zur behandlung von asthma
NO972522L (no) Monoklonale antistoffer med immunoundertrykkende aktivitet
DE59812529D1 (de) Monoklonaler Antikörper 4G8B4B12 gegen humanes FLT3/FLK2
DE69533504D1 (de) Monoklonale antikörper gegen antigene, die durch hämatopoietische helferzellen exprimiert werden
GB2284608A (en) 06-Methylguanine-DNA-methyltransferase (mgmt) specific antibodies
Leanderson et al. Effects of μ‐specific antibodies on B cell growth and maturation
ATE293685T1 (de) Monoklonaler antikörper gegen ratte beta-2- integrin alpha d untereinheit und entsprechendes hybridoma
ATE279729T1 (de) Beurteilung von cerrixzellen
ATE251643T1 (de) Antikörper 67d2 gegen cd164

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties